DSGN icon

Design Therapeutics
DSGN

Overview Fund Activity

92 hedge funds and large institutions have $116M invested in Design Therapeutics in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 35 increasing their positions, 34 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
92
Holders Change
-6
Holders Change %
-6.12%
% of All Funds
1.23%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
5
Increased
35
Reduced
34
Closed
11
Calls
$44K
Puts
–
Net Calls
+$44K
Net Calls Change
+$46K

Top Buyers

1
DCM
Driehaus Capital Management
Illinois
$3.63M
2
WP
Woodline Partners
California
$2.62M
3
KCM
Kynam Capital Management
New Jersey
$3.47M
4
TCM
Tang Capital Management
California
$6M
5
AC
Almitas Capital
California
$5.16M

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
$0
2
Citadel Advisors
Citadel Advisors
Florida
$2.83M
3
Millennium Management
Millennium Management
New York
$0
4
BlackRock
BlackRock
New York
$8.07M
5
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
$12.9K
Name Holding Trade Value Shares
Change 		Shares
Change %
Simplex Trading
101
Simplex Trading
Illinois
– -$1K -263 Closed
GI
102
GAMMA Investing
California
– -$880 -228 Closed
PS
103
Principal Securities
Iowa
– -$457 -74 Closed
1 2 3 4
5